Ubiquitin-based anticancer therapy: Carpet bombing with proteasome inhibitors vs surgical strikes with E1, E2, E3, or DUB inhibitors()

por Mattern, Michael R., Wu, Jian, Nicholson, Benjamin
Publicado 2012

SUMO fusion technology for difficult-to-express proteins

por Butt, Tauseef R., Edavettal, Suzanne C., Hall, John P., Mattern, Michael R.
Publicado 2005

Enhanced Expression and Purification of Membrane Proteins by SUMO Fusion in Escherichia coli

por Zuo, Xun, Li, Shuisen, Hall, John, Mattern, Michael R., Tran, Hiep, Shoo, Joshua, Tan, Robin, Weiss, Susan R., Butt, Tauseef R.
Publicado 2005

Active site-targeted covalent irreversible inhibitors of USP7 impair the functions of Foxp3+ T-regulatory cells by promoting ubiquitination of Tip60

por Wang, Feng, Wang, Liqing, Wu, Jian, Sokirniy, Ivan, Nguyen, Phuong, Bregnard, Thomas, Weinstock, Joseph, Mattern, Michael, Bezsonova, Irina, Hancock, Wayne W., Kumar, Suresh
Publicado 2017

Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities

por Nicholson, Benjamin, Leach, Craig A., Goldenberg, Seth J., Francis, Dana M., Kodrasov, Matthew P., Tian, Xufan, Shanks, John, Sterner, David E., Bernal, Alejandro, Mattern, Michael R., Wilkinson, Keith D., Butt, Tauseef R.
Publicado 2008

Expression and purification of SARS coronavirus proteins using SUMO-fusions

por Zuo, Xun, Mattern, Michael R., Tan, Robin, Li, Shuisen, Hall, John, Sterner, David E., Shoo, Joshua, Tran, Hiep, Lim, Peter, Sarafianos, Stefan G., Kazi, Lubna, Navas-Martin, Sonia, Weiss, Susan R., Butt, Tauseef R.
Publicado 2005